Adma Biologics reported $20.52M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Adma Biologics USD 20.52M 2M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Novavax USD 16.1M 8.48M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Takeda JPY 491.34B 23.75B Mar/2026